{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T06:49:56Z","timestamp":1781592596266,"version":"3.54.5"},"reference-count":37,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,6,9]],"date-time":"2025-06-09T00:00:00Z","timestamp":1749427200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Pregnancy Hypertension"],"published-print":{"date-parts":[[2025,9]]},"DOI":"10.1016\/j.preghy.2025.101227","type":"journal-article","created":{"date-parts":[[2025,6,3]],"date-time":"2025-06-03T02:56:27Z","timestamp":1748919387000},"page":"101227","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"C","title":["Clinical outcomes following implementation of diagnostic testing for pre-eclampsia within a UK tertiary hospital setting using angiogenic biomarkers"],"prefix":"10.1016","volume":"41","author":[{"given":"M.","family":"Gibson","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0003-7705-041X","authenticated-orcid":false,"given":"E.","family":"Tomlinson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N.","family":"Barry","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Kouvatsou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Kingdom","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E.D.","family":"Johnstone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0913-2096","authenticated-orcid":false,"given":"J.E.","family":"Myers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.preghy.2025.101227_b0005","doi-asserted-by":"crossref","DOI":"10.1136\/bmj-2022-071653","article-title":"Hypertensive disorders of pregnancy","author":"Wu","year":"2023","journal-title":"BMJ"},{"key":"10.1016\/j.preghy.2025.101227_b0010","unstructured":"Knight M, Bunch K, Felker A, Patel R, Kotnis R, Kenyon S, (Eds.) KJ, MBRRACE-UK obo. Saving Lives, Improving Mothers\u2019 Care Core Report - Lessons learned to inform maternity care from the UK and Ireland. Confidential Enquiries into Maternal Deaths and Morbidity 2019-21. Oxford: National Perinatal Epidemiology Unit,: University of Oxford 2023.; 2023."},{"key":"10.1016\/j.preghy.2025.101227_b0015","doi-asserted-by":"crossref","DOI":"10.1016\/j.preghy.2022.08.007","article-title":"Postnatal cardiovascular morbidity following preterm pre-eclampsia: An observational study","author":"Ormesher","year":"2022","journal-title":"Pregnancy Hypertens."},{"key":"10.1016\/j.preghy.2025.101227_b0020","doi-asserted-by":"crossref","DOI":"10.1016\/j.preghy.2021.09.008","article-title":"The 2021 International Society for the Study of Hypertension in Pregnancy classification, diagnosis & management recommendations for international practice","author":"Magee","year":"2022","journal-title":"Pregnancy Hypertens."},{"key":"10.1016\/j.preghy.2025.101227_b0025","article-title":"Usefulness of the sFlt-1\/PlGF (soluble fms-like tyrosine kinase-1\/placental growth factor) ratio in diagnosis or misdiagnosis in women with clinical diagnosis of preeclampsia","author":"Leanos-Miranda","year":"2020","journal-title":"Hypertension"},{"key":"10.1016\/j.preghy.2025.101227_b0030","doi-asserted-by":"crossref","DOI":"10.1111\/1471-0528.17837","article-title":"Phenotypes of maternal vascular malperfusion placental pathology and adverse pregnancy outcomes: A retrospective cohort study","author":"Zur","year":"2024","journal-title":"BJOG"},{"key":"10.1016\/j.preghy.2025.101227_b0035","doi-asserted-by":"crossref","DOI":"10.1038\/jhh.2017.61","article-title":"Placental growth factor and pre-eclampsia","author":"Chau","year":"2017","journal-title":"J. Hum. Hypertens."},{"key":"10.1016\/j.preghy.2025.101227_b0040","doi-asserted-by":"crossref","DOI":"10.1210\/jc.2003-030528","article-title":"Overexpression of the soluble vascular endothelial growth factor receptor in preeclamptic patients: pathophysiological consequences","author":"Tsatsaris","year":"2003","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.preghy.2025.101227_b0045","doi-asserted-by":"crossref","DOI":"10.1016\/j.ajog.2011.07.037","article-title":"The sFlt-1\/PlGF ratio in different types of hypertensive pregnancy disorders and its prognostic potential in preeclamptic patients","author":"Verlohren","year":"2012","journal-title":"Am. J. Obstet. Gynecol."},{"key":"10.1016\/j.preghy.2025.101227_b0050","doi-asserted-by":"crossref","DOI":"10.1056\/NEJMoa031884","article-title":"Circulating angiogenic factors and the risk of preeclampsia","author":"Levine","year":"2004","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.preghy.2025.101227_b0055","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCULATIONAHA.111.054361","article-title":"Angiogenic factors and the risk of adverse outcomes in women with suspected preeclampsia","author":"Rana","year":"2012","journal-title":"Circulation"},{"key":"10.1016\/j.preghy.2025.101227_b0060","doi-asserted-by":"crossref","DOI":"10.1056\/NEJMoa1414838","article-title":"Predictive value of the sFlt-1:PlGF ratio in women with suspected preeclampsia","author":"Zeisler","year":"2016","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.preghy.2025.101227_b0065","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCULATIONAHA.113.003215","article-title":"Diagnostic accuracy of placental growth factor in women with suspected preeclampsia: a prospective multicenter study","author":"Chappell","year":"2013","journal-title":"Circulation"},{"key":"10.1016\/j.preghy.2025.101227_b0070","doi-asserted-by":"crossref","DOI":"10.1016\/S0140-6736(18)33212-4","article-title":"Placental growth factor testing to assess women with suspected pre-eclampsia: a multicentre, pragmatic, stepped-wedge cluster-randomised controlled trial","author":"Duhig","year":"2019","journal-title":"Lancet"},{"key":"10.1016\/j.preghy.2025.101227_b0075","doi-asserted-by":"crossref","DOI":"10.1161\/HYPERTENSIONAHA.119.12739","article-title":"Randomized interventional study on prediction of preeclampsia\/eclampsia in women with suspected preeclampsia: INSPIRE","author":"Cerdeira","year":"2019","journal-title":"Hypertension"},{"key":"10.1016\/j.preghy.2025.101227_b0080","unstructured":"NICE Diagnostic guidance. PLGF-based testing to help diagnose suspected preterm pre-eclampsia. 2022 https:\/\/www.nice.org.uk\/guidance\/dg49."},{"key":"10.1016\/j.preghy.2025.101227_b0085","unstructured":"NICE Guidance. Hypertension in Pregnancy. 2010 http:\/\/guidance.nice.org.uk\/CG107."},{"key":"10.1016\/j.preghy.2025.101227_b0090","unstructured":"NHS Accelerated Access Collaborative. 2022. https:\/\/www.england.nhs.uk\/aac\/."},{"key":"10.1016\/j.preghy.2025.101227_b0095","doi-asserted-by":"crossref","DOI":"10.1159\/000339789","article-title":"KDIGO clinical practice guidelines for acute kidney injury","author":"Khwaja","year":"2012","journal-title":"Nephron Clin. Pract."},{"key":"10.1016\/j.preghy.2025.101227_b0100","doi-asserted-by":"crossref","DOI":"10.1161\/HYPERTENSIONAHA.119.13089","article-title":"Pregnancy-related acute kidney injury in preeclampsia: risk factors and renal outcomes","author":"Conti-Ramsden","year":"2019","journal-title":"Hypertension"},{"key":"10.1016\/j.preghy.2025.101227_b0105","doi-asserted-by":"crossref","DOI":"10.1016\/S0140-6736(10)61351-7","article-title":"Prediction of adverse maternal outcomes in pre-eclampsia: development and validation of the fullPIERS model","author":"von Dadelszen","year":"2011","journal-title":"Lancet"},{"key":"10.1016\/j.preghy.2025.101227_b0185","doi-asserted-by":"crossref","DOI":"10.1016\/j.ajog.2017.12.010","article-title":"The World Health Organization fetal growth charts: concept, findings, interpretation, and application","author":"Kiserud","year":"2018","journal-title":"Am. J. Obstet. Gynecol."},{"key":"10.1016\/j.preghy.2025.101227_b0110","unstructured":"National Maternity and Perinatal Audit - Clinical Report 2022. 2022. https:\/\/maternityaudit.org.uk\/FilesUploaded\/Ref%20336%20NMPA%20Clinical%20Report_2022.pdf."},{"key":"10.1016\/j.preghy.2025.101227_b0115","unstructured":"Gallimore I, Matthews R, Page G, Smith L, Fenton A, Knight M, Smith P, Redpath S, Manktelow B, Collaboration obotM-U. MBRRACE-UK Perinatal Mortality Surveillance, UK Perinatal Deaths of Babies Born in 2022: State of the Nation Report. Leicester: The Infant Mortality and Morbidity Studies, Department of Population Health Sciences, University of Leicester.; 2024. https:\/\/timms.le.ac.uk\/mbrrace-uk-perinatal-mortality\/surveillance\/#perinatal-mortality-in-the-uk."},{"key":"10.1016\/j.preghy.2025.101227_b0120","doi-asserted-by":"crossref","DOI":"10.1016\/S0140-6736(19)31963-4","article-title":"Planned early delivery or expectant management for late preterm pre-eclampsia (PHOENIX): a randomised controlled trial","author":"Chappell","year":"2019","journal-title":"Lancet"},{"key":"10.1016\/j.preghy.2025.101227_b0125","unstructured":"NHS England. Saving Babies\u2019 Lives Version Two - A care Bundle for reducing Perinatal Mortality 2019 https:\/\/www.england.nhs.uk\/wp-content\/uploads\/2019\/03\/Saving-Babies-Lives-Care-Bundle-Version-Two-Updated-Final-Version.pdf."},{"key":"10.1016\/j.preghy.2025.101227_b0130","unstructured":"NHS England. Maternity Services Monthly Statistics, September 2021, experimental statistics. 2021. https:\/\/digital.nhs.uk\/data-and-information\/publications\/statistical\/maternity-services-monthly-statistics\/september-2021-experimental-statistics."},{"key":"10.1016\/j.preghy.2025.101227_b0135","doi-asserted-by":"crossref","DOI":"10.1016\/j.ajog.2024.05.050","article-title":"Plasma soluble fms-like tyrosine kinase 1 to placental growth factor ratio of 11.5 multiples of median predicts preeclampsia with severe features within 2 weeks of testing","author":"Espinoza","year":"2024","journal-title":"Am. J. Obstet. Gynecol."},{"key":"10.1016\/j.preghy.2025.101227_b0140","article-title":"Real-world evidence for the utility of serum soluble fms-like tyrosine kinase 1\/placental growth factor test for routine clinical evaluation of hospitalized women with hypertensive disorders of pregnancy","author":"Burns","year":"2024","journal-title":"Am. J. Obstet. Gynecol."},{"key":"10.1016\/j.preghy.2025.101227_b0145","doi-asserted-by":"crossref","DOI":"10.1002\/pd.4554","article-title":"Modeling risk for severe adverse outcomes using angiogenic factor measurements in women with suspected preterm preeclampsia","author":"Palomaki","year":"2015","journal-title":"Prenat. Diagn."},{"key":"10.1016\/j.preghy.2025.101227_b0150","doi-asserted-by":"crossref","DOI":"10.1016\/j.ajog.2016.01.168","article-title":"Sequential plasma angiogenic factors levels in women with suspected preeclampsia","author":"Baltajian","year":"2016","journal-title":"Am. J. Obstet. Gynecol."},{"key":"10.1016\/j.preghy.2025.101227_b0155","doi-asserted-by":"crossref","DOI":"10.1016\/S0140-6736(23)02357-7","article-title":"Repeat placental growth factor-based testing in women with suspected preterm pre-eclampsia (PARROT-2): a multicentre, parallel-group, superiority, randomised controlled trial","author":"Hurrell","year":"2024","journal-title":"Lancet"},{"key":"10.1016\/j.preghy.2025.101227_b0160","doi-asserted-by":"crossref","DOI":"10.1016\/j.ajog.2022.05.043","article-title":"Diagnostic utility of serial circulating placental growth factor levels and uterine artery Doppler waveforms in diagnosing underlying placental diseases in pregnancies at high risk of placental dysfunction","author":"Agrawal","year":"2022","journal-title":"Am. J. Obstet. Gynecol."},{"key":"10.1016\/j.preghy.2025.101227_b0165","doi-asserted-by":"crossref","DOI":"10.1159\/000514378","article-title":"Gestational age-specific reference ranges for the sFlt-1\/PlGF immunoassay ratio in twin pregnancies","author":"De La Calle","year":"2021","journal-title":"Fetal Diagn. Ther."},{"key":"10.1016\/j.preghy.2025.101227_b0170","doi-asserted-by":"crossref","DOI":"10.1161\/HYPERTENSIONAHA.120.14957","article-title":"The prognostic value of angiogenic markers in twin pregnancies to predict delivery due to maternal complications of preeclampsia","author":"Binder","year":"2020","journal-title":"Hypertension"},{"key":"10.1016\/j.preghy.2025.101227_b0175","doi-asserted-by":"crossref","DOI":"10.1016\/j.preghy.2018.03.007","article-title":"A clinical evaluation of placental growth factor in routine practice in high-risk women presenting with suspected pre-eclampsia and\/or fetal growth restriction","author":"Ormesher","year":"2018","journal-title":"Pregnancy Hypertension"},{"key":"10.1016\/j.preghy.2025.101227_b0180","doi-asserted-by":"crossref","DOI":"10.1111\/1471-0528.15855","article-title":"Placental growth factor testing for suspected pre-eclampsia: a cost-effectiveness analysis","author":"Duhig","year":"2019","journal-title":"BJOG"}],"container-title":["Pregnancy Hypertension"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2210778925000431?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2210778925000431?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T10:27:34Z","timestamp":1778840854000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2210778925000431"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9]]},"references-count":37,"alternative-id":["S2210778925000431"],"URL":"https:\/\/doi.org\/10.1016\/j.preghy.2025.101227","relation":{},"ISSN":["2210-7789"],"issn-type":[{"value":"2210-7789","type":"print"}],"subject":[],"published":{"date-parts":[[2025,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Clinical outcomes following implementation of diagnostic testing for pre-eclampsia within a UK tertiary hospital setting using angiogenic biomarkers","name":"articletitle","label":"Article Title"},{"value":"Pregnancy Hypertension","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.preghy.2025.101227","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier B.V. on behalf of International Society for the Study of Hypertension in Pregnancy.","name":"copyright","label":"Copyright"}],"article-number":"101227"}}